Company / Capital Expenditures
BICYCLE THERAPEUTICS PLC Capital Expenditures History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$2.4M
FY2025
5-year range
$1.2M / $19.0M
FY2021-FY2025
Trend
+90.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures returned to growth in FY2025 after 2 years of decline, reaching $2M.
Based on SEC 10-K filings.
$2M in FY2025 with a 5-year CAGR of +14.4%.
Declined from $3M to $2M over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -50.2%
- 5-Year CAGR
- +14.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +14.4%, indicating consistent growth.
- In FY2025, capital expenditures increased 90.3% year-over-year.
- Peak capital expenditures was recorded in FY2022.
- Lowest capital expenditures in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.98 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.4M | +90.3% |
| FY2024 | $1.2M | -57.8% |
| FY2023 | $2.9M | -84.6% |
| FY2022 | $19.0M | +835.3% |
| FY2021 | $2.0M | +69.2% |
| FY2020 | $1.2M | -22.8% |
| FY2019 | $1.6M | - |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026